TY  - GEN 
AU  - Oitabén, A.
AU  - Fonseca, P.
AU  - Villanueva, M.J.
AU  - García-Benito, C.
AU  - Lopez Lopez, Aida
AU  - Garrido-Fernández, A.
AU  - Gonzalez Ojea, Clara
AU  - Juaneda-Magdalena, L.
AU  - Lazaro Quintela, Martín
AU  - Martínez Fernández, Mónica
PY  - 2022
SN  - 2072-6694
UR  - http://hdl.handle.net/20.500.11940/20682
AB  - Immunotherapy with Immune Checkpoint Inhibitors (ICIs) has demonstrated a profitable performance for Non-Small Cell Lung Cancer (NSCLC) cancer treatment in some patients; however, there is still a percentage of patients in whom immunotherapy does not...
LA  - eng
TI  - Emerging Blood-Based Biomarkers for Predicting Immunotherapy Response in NSCLC
DO  - 10.3390/cancers14112626
KW  - AS Vigo
KW  - CHUVI
KW  - IISGS
VL  - 14
ER  -